Certara to Participate in Upcoming Investor Conferences
Certara, Inc. (Nasdaq: CERT) has announced its participation in two upcoming investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Certara, Inc. (Nasdaq: CERT) has announced its participation in two upcoming investor conferences. The first is the Jeffries London Healthcare Conference on November 15 at 4:25 PM GMT, followed by the Stephens Annual Investment Conference on November 17 at 9:00 AM CT. Live webcasts will be available on Certara's investor relations website and can be replayed for 90 days. Certara specializes in biosimulation software and services that enhance drug discovery and development for over 2,000 clients worldwide.
Details
News Market Reaction – CERT
The recorded move for CERT in the trading session of this news was +0.85%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PRINCETON, N.J., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor conferences:
- Jeffries London Healthcare Conference
Date and Time: Tuesday, November 15 at 4:25PM GMT
- Stephens Annual Investment Conference
Date and Time: Thursday, November 17 at 9:00AM CT
Live webcasts for each of the conferences will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter.
About Certara
Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions and regulatory agencies across 62 countries.
Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com
Media Contact:
Daniel Yunger
Kekst CNC
daniel.yunger@kekstcnc.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.